Tuesday, March 31, 2015

Top 5 Building Product Companies To Watch In Right Now

Top 5 Building Product Companies To Watch In Right Now: CMS Energy Corp (CMS)

CMS Energy Corporation (CMS Energy) is an energy company operating primarily in Michigan. CMS Energy is the parent holding company of several subsidiaries, including Consumers Energy Company (Consumers) and CMS Enterprises Company (CMS Enterprises). Consumers is an electric and gas utility, and CMS Enterprises, primarily a domestic independent power producer. Consumers serves individuals and businesses operating in the alternative energy, automotive, chemical, metal, and food products industries, as well as a diversified group of other industries. CMS Enterprises, through its subsidiaries and equity investments, is engaged primarily in independent power production and owns power generation facilities fueled mostly by natural gas and biomass. CMS Energy operates in three business segments: electric utility, gas utility and enterprises, its non-utility operations and investments. EnerBank USA (EnerBank), a wholly owned subsidiary of CMS Energy, which provides unsecured consu mer installment loans for financing home improvements.

CONSUMERS ELECTRIC UTILITY

Consumers electric utility operations include the generation, purchase, distribution, and sale of electricity. During the year ended December 31, 2011, Consumers electric deliveries were 38 billion kilowatt hour, which included Retail Open Access (ROA) deliveries of four billion kilowatt hour. Consumers distribution system includes 413 miles of high-voltage distribution radial lines operating at 120 kilovolts or above; ,244 miles of high-voltage distribution overhead lines operating at 23 kilovolts and 46 kilovolts; 17 miles of high-voltage distribution underground lines operating at 23 kilovolts and 46 kilovolts; 55,953 miles of electric distribution overhead lines; 10,112 miles of underground distribution lines, and substations with an aggregate transformer capacity of 24 million thousand volt-amperes.

At December 31, 2011,! Consumers electri c generating system consisted of coal generation, oil/gas/steam generation, hydroelectric and gas/oil combustion turbine. At December 31, 2011, Consumers had contracts to purchase coal through 2014. At December 31, 2011, Consumers had 86% of its 2012 expected coal requirements under contract, as well as a 41-day supply of coal on hand. During 2011, Consumers purchased 53% of the electricity it provided to customers through long-term power purchase agreements (PPAs), seasonal purchases, and the Midwest Energy Market. Consumers offers its generation into the Midwest Energy Market on a day-ahead and real-time basis and bids for power in the market to serve the demand of its customers. Consumers is a net purchaser of power and supplements its generation capability with purchases from the Midwest Energy Market to meet its customers needs during peak demand periods.

CONSUMERS GAS UTILITY

Consumers gas utility operations include the purchase, trans mission, storage, distribution, and sale of natural gas. Consumers gas utility customer base consists of a mix of residential, commercial, and diversified industrial customers in Michigans Lower Peninsula. In 2011, deliveries of natural gas, including off-system transportation deliveries, through Consumers pipeline and distribution network, totaled 337 billion cubic feet of gas, which included Gas Customer Choice (GCC) deliveries of 48 billion cubic feet of gas. Consumers gas utility operations are seasonal. During 2011, 46% of the natural gas supplied to all customers during the winter months was supplied from storage.

Consumers gas distribution and transmission system located in Michigans Lower Peninsula consists of 26,623 miles of distribution mains; 666 miles of transmission lines; seven compressor stations with a total of 150,635 installed and available horsepower, and 15 gas storage fields with an aggregate storage capacity of 307 billion cubic feet of gas and a working storage capacity of 142 bil! lion cubi! c feet of gas. In 2011, Consumers purchased 70% of the gas it delivered from United States producers and 10% from Canadian producers. The remaining 20% was purchased from authorized GCC suppliers and delivered by Consumers to customers in the GCC program.

ENTERPRISES SEGMENT

CMS Energys enterprises segment, through various subsidiaries and certain equity investments, is engaged primarily in domestic independent power production and the marketing of independent power production. At December 31, 2011, CMS Energy had ownership interests in independent power plants totaling 1,135 gross megawatts or 1,034 net megawatts. CMS Energy Resource Management (ERM) purchases and sells energy commodities in support of CMS Energys generating facilities and continues to focus on optimizing CMS Energys independent power production portfolio. In 2011, CMS ERM marketed 17 billion cubic feet o f natural gas and 2,417 gigawatt-hour of electricity.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on CMS Energy (NYSE: CMS  ) , whose recent revenue and earnings are plotted below.

  • [By David Dittman]

    CMS Energy Corp (NYSE: CMS), which at 47.5 percent had the largest share of coal-fired generation among power producers in the UF Portfolio, was down just 0.1 percent.

  • [By Alex Planes]

    Looking for a way to invest in hydropower? California's PG&E (NYSE: PCG  ) is the nation's largest hydropower utility, producing nearly 12 billion kilowatt-hours of water-sourced electricity each year. CMS Energy (NYSE: CMS  ) , which currently operates 13 hydroelectric power plants in Michigan -- including one near the site of th! at first ! Grand Rapids turbine -- provides power to about 70,000 people each year from the movement of water.

  • [By ovenerio]

    The company has a current ROE of 11.16% which is higher than the industry median. Also, it is higher than the one exhibit by Ameren (AEE). In general, analysts consider ROE ratios in the 15-20% range as representing attractive levels for investment. So, for investors looking at those levels, Wisconsin Energy (WEC) and CMS Energy (CMS) could be the options. It is very important to understand this metric before investing, and it is important to look at the trend in ROE over time.

  • source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-5-building-product-companies-to-watch-in-right-now.html

Monday, March 30, 2015

5 Best India Stocks To Buy Right Now

5 Best India Stocks To Buy Right Now: Sify Technologies Limited(SIFY)

Sify Technologies Limited provides enterprise and consumer Internet services primarily in India. The company offers various corporate network/data services comprising e-commerce and network connectivity solutions, such as end-to-end services network, application, and security services; voice origination and termination services; co-location and managed hosting services; and system integration services for data centre build, hardware distribution, security solutions, and turnkey projects. It also provides application services, including SLEMS and Microsoft Exchange messaging platforms; I-test for online assessment and LiveWire, which enable management of training processes across the organization; document management system for the management of documents electronically; and Forum, a forward supply chain solution. In addition, the company operates e-Ports that offer browsing, chat, email, gaming, utility bill payment, travel ticketing, hotel booking, mobile recharge, Intern et telephony, and online share trading services; and portals, which provide news, views, reviews, interactions, and services in the areas of movies, sports, finance, food, videos, astrology, online games, shopping, and travel, as well as offers content offerings and broadband services. Further, it provides infrastructure management services, such as network management, datacenter and helpdesk outsourcing, desktop and storage outsourcing, IT security outsourcing, LAN and WAN outsourcing, database and telecom outsourcing, and application monitoring and management services to automotive, chemical, media, and financial enterprises; and virtualization design, integration, and deployment services for servers, storage, networks, and end user clients. Sify has approximately 1,278 e-Ports in 200 towns and cities; and serves 1,06,000 broadband subscribers through 1500 cable TV Op! erators. The company, formerly known as Sify Limited, was founded in 1995 and is based in Chennai, India. Advisors' Opinion:

  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Technology stocks gained Tuesday, with Ku6 Media Co (NASDAQ: KUTV) leading advancers. Among leading tech stocks, gains came from Rubicon Technology (NASDAQ: RBCN), Bitauto Holdings (NYSE: BITA) and Sify Technologies (NASDAQ: SIFY).

  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Technology stocks gained Tuesday, with Ku6 Media Co (NASDAQ: KUTV) leading advancers. Among leading tech stocks, gains came from Rubicon Technology (NASDAQ: RBCN), Bitauto Holdings (NYSE: BITA) and Sify Technologies (NASDAQ: SIFY). Utilities shares dropped by 0.11 percent in the US market today.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/5-best-india-stocks-to-buy-right-now-2.html

Sunday, March 29, 2015

Top Food Companies To Invest In 2014

One almost has to feel sorry for old school small cap marijuana stocks like Medical Marijuana Inc (OTCMKTS: MJNA), Cannabis Science Inc (OTCMKTS: CBIS) and�Hemp Inc�(OTCMKTS: HEMP) which have been around awhile and increasingly have to contend with the marijuana newswires getting flooded with news from every small cap OTC stock along with�your mother�� uncle�� fifth cousin trying to grab a piece of the marijuana�hype. We alone had two specific articles (Small Cap Marijuana Stocks Aiming for a High With News: MCIG, FRTD & SKTO�and Four Marijuana Small Caps Giving Investors Highs or Lows: ENRT, VMGI, NVLX & RTXBQ) covering about half a dozen different wannabe marijuana stocks with news for�just this week along with another article (Putting My Call on Latteno Food in Perspective, Take-Two (LATF, MJNA, ERBB)) about another small cap that�� infusing food with weed.�

Top 5 Information Technology Companies To Invest In Right Now: 1-800 FLOWERS.COM Inc.(FLWS)

1-800-Flowers.com, Inc. together with its subsidiaries, operates as a florist and gift retailer in the United States. The company offers a range of products, including fresh-cut flowers, floral arrangements and plants, gifts, popcorn, gourmet foods and gift baskets, cookies, chocolates, candy, and wine through its telephonic and online sales channels, company-owned and operated retail floral stores, and franchised stores. It provides gourmet gifts, such as popcorn and specialty treats through thepopcornfactory.com; cookies and baked gifts through cheryls.com; chocolates and confections through fanniemay.com and harrylondon.com; gift baskets and towers through 1800baskets.com; Celebrations brand party ideas and planning tips through celebrations.com; and customizable invitations, announcements, and greeting cards through finestationery.com. As of July 3, 2011, the company operated 2 floral retail stores, 1 fulfillment center, and approximately 100 franchised stores located within the United States. It has strategic online relationships with Facebook, Google, AOL, Yahoo!, and Microsoft. The company was founded in 1976 and is headquartered in Carle Place, New York.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on 1-800-Flowers.com (Nasdaq: FLWS  ) , whose recent revenue and earnings are plotted below.

Top Food Companies To Invest In 2014: Nestle SA (NESN)

Nestle SA is a Swiss Company engaged in the nutrition, health and wellness sectors. It is the holding company of the Nestle Group, which comprises subsidiaries, associated companies and joint ventures throughout the world. It has such business units as Food and Beverage, Nestle Waters and Nestle Nutrition. It is also active in the pharmaceutical sector. It divides its products into Powdered and liquid beverages, Water, Milk products and Ice cream, Nutrition, Prepared dishes and cooking aids, Confectionery, PetCare and Pharmaceutical products. In February 2011, the Company acquired CM&D Pharma Ltd. Advisors' Opinion:
  • [By Corinne Gretler]

    Swiss stocks fell for a second day, their first back-to-back losses this month, as Nestle (NESN) SA retreated after reporting slower growth in sales.

  • [By Chad Fraser]

    These are the first significant moves made by the Caira, a former executive at Nestle SA (NYSE: NESN) who helped expand that company’s hot and cold beverage division.

  • [By Celeste Perri]

    Nestle SA (NESN) is selling Givaudan (GIVN) SA shares worth $1.27 billion at yesterday�� closing price to institutional investors, winding down its stake in the world�� largest flavorings maker.

Top Food Companies To Invest In 2014: Kraft Foods Group Inc (KRFT)

Kraft Foods Group, Inc. (Kraft Foods Group), incorporated on March 16, 2012, operates food and beverage businesses in North America. The Company manufactures and markets food and beverage products, including convenient meals, refreshment beverages and coffee, cheese and other grocery products, in the United States and Canada, under a stable of iconic brands. Its product categories span breakfast, lunch and dinner meal occasions, both at home and in foodservice locations. The Company sells its products to supermarket chains, wholesalers, supercenters, club stores, mass merchandisers, distributors, convenience stores, drug stores, gasoline stations, value stores and other retail food outlets in the United States and Canada. On September 14, 2012, the Company�� parent company, Kraft Foods Inc. (Kraft ParentCo), issued a press release relating to the anticipated trading markets for Kraft Foods Inc. and Kraft Foods Group, Inc. common stock through the completion of its spin-off from Kraft Foods Inc. In October 2012, Mondelez International, Inc. completed the spin-off of North American grocery business, Kraft Foods Group. In June 2013, Kraft Foods Group Inc announced plans to create two new, standalone business units: Meals and Desserts, and Enhancers and Snack Nuts.

The Company�� brand portfolio consists of food brands in North America, including three brands: Kraft cheeses, dinners and dressings; Oscar Mayer meats, and Maxwell House coffees- plus over 20 brands. It manufactures and sells food and beverage products in 50 categories. The Company operates in five segments: U.S. Beverages, which manufactures packaged juice drinks, powdered beverages and coffee; U.S. Cheese, which manufactures processed, natural and cream cheeses; U.S. Convenient Meals, which manufactures processed meats and lunch combinations; U.S. Grocery, which manufactures spoonable and pourable dressings, condiments, desserts, packaged dinners and snack nuts, and Canada & N.A. Foodservice, which sells products that span ! all of its segments and includes the Canadian and Puerto Rico grocery business, the North American foodservice operations and the North American Grocery Export Business.

U.S. Beverages

During the year ended December 31, 2011, the Company�� U.S. Beverages segment contributed 16% of its combined net revenues. This segment manufactures refreshment beverages, including Capri Sun (under license) and Kool-Aid packaged juice drinks, Kool-Aid, Crystal Light and Country Timepowdered beverages and MiO liquid concentrate, and coffee products, including Maxwell House, Gevalia and Yuban coffees, Maxwell House Internationalbeverage mixers and Tassimo (under license) hot beverage system.

U.S. Cheese

During 2011, U.S. Cheese segment had contributed 20% of the Company�� combined net revenues. This segment manufactures processed cheese, including Velveeta and Cheez Whiz processed cheeses, Kraft and Deli Deluxe processed cheese slices, Kraft grated cheeses and Polly-O and Athenos hummus and cheeses; natural cheese, including Kraft and Cracker Barrel natural cheeses, and cream cheese, including Philadelphia cream cheese and cooking creme.

U.S. Convenient Meals

During 2011, the Company�� U.S. Convenient Meals segment contributed 18% of its combined net revenues. This segment�� principal brands and products include Oscar Mayer lunch meats, hot dogs and bacon, Lunchables lunch combinations, Boca soy-based meat alternatives, and Claussen pickles.

U.S. Grocery

During 2011, the Company�� U.S. Grocery segment contributed 25% of its combined net revenues. This segment�� principal brands and products include Kraft and Kraft Deluxe macaroni & cheese dinners, Planters nuts, trail mixes and peanut butter, Corn Nuts corn snacks, Jell-O dry packaged desserts and refrigerated gelatin and pudding snacks, Cool Whip whipped topping, Jet-Puffed marshmallows, Baker�� chocolate and baking ingredients, Kraft and Miracle Whip sp! oonable d! ressings, Kraft and Good Seasons salad dressings, A.1. steak sauce, Kraft and Bull��-Eye barbecue sauces, Grey Poupon mustards, Shake N��Bake coatings, Stove Top stuffing mix, Taco Bell Home Originals (under license) meal kits, Velveeta shells and cheese dinners, and Velveeta Skillets meal kits.

Canada & N.A. Foodservice

During 2011, the Company�� Canada & N.A. Foodservice segment contributed 21% of its combined net revenues. The principal products and brands in this segment span all of its segments. Canadian grocery offerings include Nabob coffee and Kraft peanut butter, as well as a range of products in the Grocery Business Lines. The North American foodservice business sells branded products, including Maxwell House coffee, A.1. steak sauce and a range of Kraft sauces, dressings and cheeses, and serves the needs of restaurants and other foodservice operations. Puerto Rico grocery offerings include all grocery business lines, except for powdered and liquid concentrate beverages, such as Crystal Light, Tang and MiO. The North American Grocery Export Business products and brands span all grocery business lines, except for powdered and liquid concentrate beverages and certain products sold under brands, such as Philadelphia cream cheese and Kraftmayonnaise, which marketed and sold locally by Kraft ParentCo in countries outside the United States and Canada.

Advisors' Opinion:
  • [By Marc Bastow]

    Food and beverage operator Kraft Foods (KRFT) announced a 5% dividend increase to 52.5 cents per share, payable Oct. 21 to shareholders of record as of Oct. 11.
    KRFT Dividend Yield: 3.93%

  • [By Rich Duprey]

    And because the�regulatory agency has not stepped in, the trial lawyers have filled the void.�Whole Foods Market (NASDAQ: WFM  ) has been sued�because its "natural" private-label soda�contained caramel flavoring, citric acid, and carbon dioxide. Kraft Foods' (NASDAQ: KRFT  ) "all natural" Capri-Sun was sued previously because it contained�high fructose corn syrup�and�Kellogg's Kashi brand has been similarly sued because it contains bromelain, an enzyme derived from pineapples, which requires acetone in its production.

Top Food Companies To Invest In 2014: Chiquita Brands International Inc. (CQB)

Chiquita Brands International, Inc., together with its subsidiaries, engages in the distribution and marketing of bananas and fresh produce under the Chiquita and other brand names worldwide. The company operates in three segments: Bananas, Salads and Healthy Snacks, and Other Produce. The Banana segment sources, transports, markets, and distributes bananas to retailers and wholesalers, and chain stores. It also engages in the cultivation and production of bananas. The Salads and Healthy Snacks segment offers value-added salads under the Fresh Express and other labels; and fresh vegetable and fruit ingredients used in foodservice, healthy snacks, and processed fruit ingredient products. This segment also provides fresh-cut products, such as lettuce, tomatoes, spinach, cabbage, and onions to foodservice distributors who resell these products to foodservice operators. It distributes Fresh Express branded products to food retailers, foodservice distributors, and quick-service restaurants; and fresh produce foodservice offerings primarily to third-party distributors for resale principally to quick-service restaurants in the United States. The Other Produce segment engages in sourcing, marketing, and distributing fresh fruits and vegetables other than bananas in Europe and North America. It offers grapes, pineapples, melons, kiwis, tomatoes, and avocados. The company was founded in 1899 and is headquartered in Cincinnati, Ohio.

Advisors' Opinion:
  • [By Jayson Derrick]

    Chiquita Brands (NYSE: CQB) shareholders officially rejected a plan to merge with Fyffes during a special shareholder meeting that took place this morning. The company will now enter discussions with Cutrale/Safra over its $14.50 a share offer. Shares of Chiquita gained 2.91 percent, closing at $14.16.

  • [By Rich Smith]

    Charlotte, N.C.-based Chiquita Brands (NYSE: CQB  ) will soon have a new chief financial officer -- and a new chief operating officer, too. Sort of.

  • [By Sara Murphy]

    Furthermore, the court's finding does not undermine the use of the ATS in cases of human rights abuses. It just requires a stronger connection to the United States. That means that other ATS cases currently working their way through the legal system, such as Earth Rights International's case against Chiquita (NYSE: CQB  ) for allegedly funding and arming Colombian terrorists, are still on track. That also means that the link from human rights violations to corporate liability remains.

Top Food Companies To Invest In 2014: Suedzucker Mannheim Ochsenfurt AG (SZU)

Suedzucker Mannheim Ochsenfurt AG is a Germany-based company engaged in the processing of agricultural raw materials. The Company is organized, along with its subsidiaries, into four segments: the Sugar segment comprises sugar production and the agricultural division; the Special Products segment includes the activities of four divisions: BENEO, which produces and sells ingredients made from natural raw materials for food products and animal feed; the Freiberger Group is a producer of chilled and frozen pizzas, frozen pasta dishes and snacks; the PortionPack Europe group specializes in portion packs, and the starch division comprises starch companies in Hungary and Romania, bio-ethanol production in Austria and Hungary, as well as starch production facilities in Austria; the CropEnergies segment includes the bio-ethanol activities of the Company in Germany, Belgium and France, and the Fruit segment comprises the fruit juice preparations and fruit juice concentrates divisions. Advisors' Opinion:
  • [By Jonathan Morgan]

    Volkswagen AG (VOW), Europe�� biggest automaker, climbed 3.7 percent as data showed European car sales increased for the first time in 19 months in April. Suedzucker AG (SZU) dropped to an eight-month low as J&E Davy Holdings Ltd. downgraded the shares.

Top Food Companies To Invest In 2014: SuperValu Inc.(SVU)

SUPERVALU INC., together with its subsidiaries, operates retail food stores in the United States. Its stores offer grocery, general merchandise, health and beauty care, pharmacy, and fuel products. The company operates stores under the Acme, Albertsons, Cub Foods, Farm Fresh, Hornbacher?s, Jewel-Osco, Lucky, Shaw?s, Shop ?n Save, Shoppers Food & Pharmacy, and Star Market banners, as well as in-store pharmacies under the Osco and Sav-on banners. It operates approximately 2,394 traditional and hard-discount retail food stores, including 899 licensed Save-A-Lot stores. The company also offers supply chain services, which include wholesale distribution of products to independent retailers, including single and multiple grocery store independent operators, regional and national chains, mass merchants, and the military customers, as well as provides logistics support services. SUPERVALU was founded in 1871 and is based in Eden Prairie, Minnesota.

Advisors' Opinion:
  • [By Jeremy Bowman]

    What: SUPERVALU (NYSE: SVU  ) was looking like a steal today, climbing as much as 12% after reporting quarterly earnings this morning.

    So what: The once-battered supermarket stock has come roaring back in the past several months, gaining more than 250% at today's peak from its bottom last fall. SUPERVALU actually opened the day lower as its adjusted earnings fell to negative $0.14 a share from a gain of $0.02 a share in the quarter a year ago. Without adjustments, the company actually lost $6.65 per share this quarter. Still, the stock jumped on comments from management about prospects for its Save-A-Lot chain,�and plans to revamp SUPERVALU's cost structure under the direction of new CEO Sam Duncan. Duncan talked up the steps the company's taken to "right-size" corporate overhead and decentralize leadership in the earnings release.

Hot European Stocks To Own For 2015

Hot European Stocks To Own For 2015: Flamel Technologies S.A.(FLML)

Flamel Technologies S.A., a biopharmaceutical company, engages in the development and commercialization of controlled-release therapeutic products based on its proprietary polymer based technology in the United Kingdom, Ireland, the United States, France, and Europe. The company develops nanogel Medusa technology, which is intended to provide controlled release following injection of therapeutic proteins, peptides, and other molecules; a microparticle adaptation of the Medusa platform that is intended for use in the delivery of smaller proteins and peptides; and Micropump technology, a microparticle technology for oral administration of small molecule drugs with applications in controlled-release, taste-masking, and bioavailability enhancement; and Trigger-Lock technology, an adaptation based on Micropump technology, which is intended to minimize the misuse and abuse of medications subject to abuse. Its principal product based on Micropump technology is Coreg CR, which is intended for the treatment of moderate to severe heart failure and left ventricular dysfunction following myocardial infarction. The company?s products under development based upon Medusa technology include Interferon-alpha, a naturally occurring protein that the body uses for the treatment of Hepatitis C virus and as a immune response; and FT-105, an injectable insulin formulation for diabetic patients. Its products based on its Micropump technology comprise LiquiTime for the elderly and pediatric patient patients, or others who have difficulty swallowing. The company has strategic alliance with Baxter International, Inc.; GlaxoSmithKline; Merck Serono; and Pfizer Inc, as well as has a joint development agreement with Digna Biotech, S.L. Flamel Technologies S.A. was founded in 1990 and is headquartered in Venissieux, France.

Advisors' Opinion:
  • [By Garrett Cook]

    Healthcare shares gained 0.81 percent in the US market on! Friday. Top gainers in the sector included Shire plc (NASDAQ: SHPG), StemCells (NASDAQ: STEM), and Flamel Technologies SA (NASDAQ: FLML).

  • [By Anna Prior]

    Flamel Technologies SA(FLML) said the U.S. Food and Drug Administration has approved the company’s new drug application for Vazculep, an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. American depositary shares rose 5.1% to $14.78 in premarket trading.

  • [By Garrett Cook]

    Healthcare shares gained 0.81 percent in the US market on Friday. Top gainers in the sector included Shire plc (NASDAQ: SHPG), StemCells (NASDAQ: STEM), and Flamel Technologies SA (NASDAQ: FLML).

  • source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/hot-european-stocks-to-own-for-2015.html

Saturday, March 28, 2015

Best Canadian Companies To Buy For 2014

The first quarter provided very attractive returns for investors, as balanced funds performed well. The Canadian stock market led the way with a 6% return as the Materials sector rebounded from a weak 2013. The S&P500, in Canadian dollars, almost matched the S&P/TSX Composite with a return of 5.8% and the EAFE index, in Canadian dollars, was not far behind returning 4.6%. Bond yields retraced some of their 2013 increases in January, giving bond investors close to 3% returns for the quarter.

Over the past 12 months, bond markets have primarily been driven by expectations for the anticipated path towards interest rate normalization. On March 19, new Federal Reserve Bank chair Janet Yellen provided further clarity as to how that path could evolve. Her comments indicated that the current bond purchase program should end sometime this Fall. This was somewhat earlier than previous expectations that the program would end closer to December. In addition, during the press conference she explained that a reasonable expectation for the gap between the end of bond buying and the beginning of interest rate hikes should be approximately six months.

5 Best Tech Stocks To Own Right Now: Research in Motion Limited(RIMM)

Research In Motion Limited (RIM) designs, manufactures, and markets wireless solutions for the worldwide mobile communications market. The company, through the development of integrated hardware, software, and services, provides platforms and solutions for seamless access to time-sensitive information, including email, phone, short messaging service, and Internet and Intranet-based applications and browsing. Its products and services principally comprise the BlackBerry wireless platform, the RIM Wireless Handheld product line, software development tools, and other software and hardware. The company?s BlackBerry smartphones use wireless, push-based technology that delivers data to mobile users? business and consumer applications. Its BlackBerry smartphone portfolio includes BlackBerry Bold series, the BlackBerry Torch, BlackBerry Curve series, the BlackBerry Style, BlackBerry Storm series, the BlackBerry Tour, BlackBerry Pearl series, and the BlackBerry PlayBook tablet. T he company?s BlackBerry enterprise solutions comprise BlackBerry enterprise server, BlackBerry enterprise server express, BlackBerry mobile voice system, and hosted BlackBerry services. Its technology also enables third party developers and manufacturers to enhance their products and services through software development kits, wireless connectivity to data, and third-party support programs. In addition, the company offers BlackBerry technical support services, non-warranty repairs, and nonrecurring engineering services. Further, it provides BlackBerry App World that offers BlackBerry smartphone users an electronic catalogue that aids in the discovery and download/purchase of applications directly from their BlackBerry smartphone. The company markets and sells its BlackBerry wireless solutions primarily through global wireless communications carriers, and third party distribution channels. Research In Motion Limited was founded in 1984 and is headquartered in Waterloo, Canad a.

Advisors' Opinion:
  • [By GuruFocus] rch-In-Motion is a high-profile case as renowned investor Prem Watsa bought into the company and sits on the company�� board. The stock was traded at above $140 in 2008. It has since lost more than 95%, traded at single digits and still sinking.

    Again let�� take a look at its gross margin:

    While BlackBerry was a must-have in the corporate world, the profit margin of Research-In-Motion has started to decline. This was well before Apple (AAPL) released its first iPhone. Again as pointed by Adib, value investors did not buy into RIMM while it was traded at $140 because the P/E ratio then was 45. Value investors bought into RIMM while it was traded at $30-40 because the P/E ratio was at 10. This was in 2009 and the decline in profit margin had been happening for three years.

    Why You Should Avoid Margin Decliners?

    The reason is simple. The company is losing its price power or it never had price power. Competition is eating into its market.

    Will the profit margin of these companies ever recover sustainably? That is a ��oo-hard��question. We should avoid situations where we have to answer this question.

    Will these companies ever become good investments? They may. But not until they become net-nets.

    The Power of Margin Expansion

    On the other hand, if a company can expand its profit margin, it has a competitive advantage. A good example here is Apple (AAPL), which is the king of all margin-expanding companies:

    We all know what has happened to the stock of Apple.

    What�� Next?

    GuruFocus will release a feature called ��arning Signs��which will warn you about the problems a company may have, including margin declines.

    In the meantime, our new ��ll-In-One Screener��allows you to screen for the companies that can expand profit margins or those with declining margins. Those with expanding profit margins (think Apple) at reasonable prices will mostly likely be rewarding. Those

  • [By Geoff Gannon]

    This isn�� really true. A stock that is expected to have constant losses in the future ��but has earnings today ��should see no relationship between its current price and its past 12 months of earnings. In reality, there will always be some relationship. Some people buy things like Research in Motion (RIMM) as part of a regular habit of betting that the market gets overly pessimistic when it knocks a company�� P/E down deep into the single digits. They may be right. There are always some value investors like this who buy things purely because they are statistically cheap.

  • [By Holly LaFon]

    If an idea doubles within a year, the contestant will win more. This month, GuruFocus is awarding author Jean-Francois Nobert (Ecotycoon) $1,000 for his idea, Research In Motion (RIMM), which doubled since he submitted in July.

Best Canadian Companies To Buy For 2014: Everest Re Group Ltd.(RE)

Everest Re Group, Ltd., together with its subsidiaries, underwrites reinsurance and insurance in the United States (the U.S.), Bermuda, and international markets. The company operates in five segments: U.S. Reinsurance, U.S. Insurance, Specialty Underwriting, International, and Bermuda. The U.S. Reinsurance segment writes property and casualty reinsurance, on both a treaty and facultative basis, through reinsurance brokers, as well as directly with ceding companies within the United States. The U.S. Insurance segment offers property and casualty insurance primarily through general agents, brokers, and surplus lines brokers in the U.S. The Specialty Underwriting segment writes accident and health, marine, aviation, and surety business within the U.S. and worldwide through brokers and directly with ceding companies. The International segment offers non-U.S. property and casualty reinsurance. The Bermuda segment provides reinsurance and insurance to worldwide property and cas ualty markets and reinsurance to life insurers through brokers and directly with ceding companies, as well as offers reinsurance to the United Kingdom and European markets. The company was founded in 1973 and is based in Liberty Corner, New Jersey.

Advisors' Opinion:
  • [By Marc Bastow]

    Reinsurance and insurance underwriters Everest Re Group (RE) raised its dividend 56% to 75 cents per share, payable on Dec. 18 to shareholders of record as of Dec. 4.
    RE Dividend Yield: 1.92%

  • [By John Emerson]

    Last August, I purchased Everest Re (RE) when it fell within the value parameters outlined in today's article. I wrote an article about the stock titled: Everest Re: Low Risk High Reward http://www.gurufocus.com/news/143388/everest-re-low-risk-high-reward

Best Canadian Companies To Buy For 2014: Tim Hortons Inc.(THI)

Tim Hortons Inc. develops, franchises, and operates quick service restaurants primarily in Canada and the United States. Its restaurants serve coffee and other hot and cold beverages, baked goods, sandwiches, soups, and other food products. As of April 03, 2011, the company and its restaurant owners operated 3,169 restaurants in Canada and 613 restaurants in the United States under the Tim Hortons name; and had 274 primarily self-serve licensed locations in the Republic of Ireland and the United Kingdom Tim Hortons Inc. was founded in 1964 and is based in Oakville, Canada.

Advisors' Opinion:
  • [By MONEYMORNING.COM]

    It appears that the move by Warren Buffett-backed Burger King Worldwide Inc. (NYSE: BKW) to buy iconic Canadian fast food chain Tim Hortons Inc. (USA) (NYSE: THI) and relocate to Canada to lower its corporate tax rate was the straw that broke the camel's back when it comes to tax inversion deals.

  • [By Rich Duprey]

    Canadian restaurant chain�Tim Horton's� (NYSE: THI  ) �declared today�its regular quarterly dividend of $0.26 per share, slightly higher than the $0.2534 per share it paid back in February.�

  • [By Ben Levisohn]

    Burger King Worldwide�(BKW) has climbed 7.9% to $29.25�on reports that the hamburger joint is considering the purchase of Canadian coffee-outlet Tim Hortons�(THI) for the tax benefits. Tim Hortons has gained 15% to $72.00.

Best Canadian Companies To Buy For 2014: S&P 500/Barra Value(SU)

Suncor Energy Inc., together with its subsidiaries, operates as an integrated energy company. The company involves in the development of petroleum resource basins in Canada's Athabasca oil sands; acquisition, exploration, development, production, and marketing of crude oil and natural gas in Canada and internationally; transportation and refining of crude oil; and marketing of petroleum and petrochemical products primarily in Canada. Its Oil Sands segment produces bitumen recovered from oil sands through mining and in-situ technology, and upgrades it into refinery feedstock, diesel fuel, and by-products. This segment?s products include gasoline and distillates. The company?s Natural Gas segment acquires, explores, develops, and produces natural gas, natural gas liquids, oil, and by-products from reserves located primarily in western Canada, the Northwest Territories, Alaska, and the Arctic Islands. Its International and Offshore segment engages in the exploration and pro duction of oil and gas in offshore Newfoundland and Labrador, in the North Sea, and in Libya and Syria. The company?s Refining and Marketing segment refines crude oil at Suncor's refineries in Edmonton, Alberta; Montreal, Quebec; and Sarnia, Ontario in Canada, as well as in Commerce City, Colorado into a range of petroleum and petrochemical products for sale to retail, commercial, and industrial customers. It also transports crude oil through pipelines in eastern and western Canada, as well as through wholly-owned pipelines in Wyoming and Colorado; and produces specialty lubricants and waxes. In addition, this segment operates retail sites in Canada under the Petro-Canada brand; and in Colorado under Phillips 66 and Shell brands. Suncor Energy Inc. also engages in third-party energy trading activities. The company was formerly known as Suncor Inc. and changed its name to Suncor Energy Inc. in April 1997. Suncor Energy Inc. was founded in 1953 and is headquartered in Calgary , Canada.

Advisors' Opinion:
  • [By Tyler Crowe]

    According to former Suncor Energy (NYSE: SU  ) CEO, Rick George, oil sands producers need to do a better job improving the image of this particular type of oil. While the unflattering image that oil sands production has among the general public is probably not helping, there are much bigger fish for oil sands producers to fry. Increased operating costs, labor shortages, and a lack of takeaway capacity are just a few of the major problems that oil sands producers need to address to get the most from this emerging energy source.

Best Canadian Companies To Buy For 2014: Goldcorp Incorporated(GG)

Goldcorp Inc. engages in the acquisition, exploration, development, and operation of precious metal properties in Canada, the United States, Mexico, and Central and South America. It produces and sells gold, silver, copper, lead, and zinc. The company was founded in 1954 and is headquartered in Vancouver, Canada.

Advisors' Opinion:
  • [By Ben Levisohn]

    Gold miners, however, are not participating in the rally today. Newmont Mining (NEM) has dropped 1.8% to $32.62, Goldcorp (GG) has gained 0.1% to $31.30 and Barrick Gold (ABX) has fallen 1.6% to $19.50. The Market Vectors Goldminers ETF (GDX) has fallen 1.1% to $30.09.

Best Canadian Companies To Buy For 2014: Imperial Oil Limited(IMO)

Imperial Oil Limited engages in the exploration, production, and sale of crude oil and natural gas in Canada. The company operates through three segments: Upstream, Downstream, and Chemical. The Upstream segment engages in the exploration and production of conventional crude oil, natural gas, synthetic oil, and bitumen primarily in the Western Provinces, the Canada Lands, and the Atlantic Offshore. Its primary conventional oil producing asset includes the Norman Wells oil field in the Northwest Territories. The Downstream segment engages in the transportation and refining of crude oil, as well as blending, distribution, and marketing of refined products. It owns and operates crude oil, and natural gas liquids and products pipelines in Alberta, Manitoba, and Ontario. The Chemical segment engages in the manufacture and marketing of various petrochemicals, including ethylene, benzene, aromatic and aliphatic solvents, plasticizer intermediates, and polyethylene resin. As of De cember 31, 2010, Imperial Oil Limited had 1,204 million oil-equivalent barrels of proved undeveloped reserves; maintained a nation-wide distribution system, including 24 primary terminals, to handle bulk and packaged petroleum products moving from refineries to market by pipeline, tanker, rail, and road transport; and sold petroleum products through 1,850 Esso retail service stations, of which approximately 510 were company owned or leased. The company was founded in 1880 and is headquartered in Calgary, Canada. Imperial Oil Limited operates as a subsidiary of Exxon Mobil Corporation.

Advisors' Opinion:
  • [By Aaron Levitt]

    For Imperial Oil (IMO), it�� good to have friends in high places. In this case, we��e talking about Exxon�� (XOM) 70% stake in the Canadian integrated oil firm. That relationship has provided plenty of capital and technological know-how to produce plenty of crude oil and natural gas via conventional and unconventional means.

Best Canadian Companies To Buy For 2014: Natural Gas(NG)

NovaGold Resources Inc., through its subsidiaries, engages in the exploration and development of mineral properties primarily in North America. The company primarily explores for gold, silver, copper, zinc, and lead ores. It holds interests in the Donlin Creek property covering 81,361 acres and the Ambler property comprising 90,614 acres located in Alaska; and the Galore Creek property comprising 293,838 acres located in northwestern British Columbia, Canada. The company was formerly known as NovaCan Mining Resources (1985) Limited and changed its name to NovaGold Resources Inc. in March 1987. NovaGold Resources Inc. was founded in 1984 and is based in Vancouver, Canada.

Advisors' Opinion:
  • [By Holly LaFon]

    He increased his holdings in gold companies in the fourth quarter accordingly. Gold stocks he found attractive in the fourth quarter are: Novagold Resources (NG), Randgold Resources (GOLD), Iamgold Corp. (IAG), Barrick Gold Corp. (ABX), Agnico Eagle (AEM) and International Tower Hill (THM).

Friday, March 27, 2015

Best Forestry Companies For 2014

Energy is one of the most critical inputs to the global economy; it heats homes, powers factories and, perhaps most importantly, fuels our cars, trucks and planes. Without energy, no value is added at any link in the economic chain. As a result, the economy as a whole ��and inflation ��is critically sensitive to virtually any shift in global energy prices and oil is energy. That is why rising oil prices tend to play such a causative role in rising inflation.

Interestingly, though, while average gasoline prices have taken a sharp rise since late October, up from an average of $3.19 to the current national average of $3.66, oil prices have been remarkably stable. Despite spikes related to the Russian invasion of Ukraine�� Crimea region and other potential supply disruptions, as you can see from the chart below, the price of oil has been quite stable relative to historical experience.

Top High Dividend Companies To Own For 2015: CRB Futures Index(CR)

Crane Co. manufactures and sells engineered industrial products in the United States and internationally. The company operates in five segments: Aerospace & Electronics, Engineered Materials, Merchandising Systems, Fluid Handling, and Controls. The Aerospace & Electronics segment offers pressure, fuel flow, and position sensors and subsystems; brake control systems; coolant, lube and fuel pumps; and seat actuation products. This segment also provides power supplies and custom microelectronics for aerospace, defense, medical, and other applications; and electrical power components, power management products, electronic radio frequency, and microwave frequency components and subsystems for the defense, space, and military communications markets. The Engineered Materials segment manufactures fiberglass-reinforced plastic panels for the truck trailer and recreational vehicle markets, industrial markets, and the commercial construction industry. The Merchandising Systems segmen t offers vending solutions, such as food, snack, and beverage vending machines; and vending machine software and online solutions, as well as payment solutions, including coin accepters and dispensers, coin hoppers, coin recyclers, bill validators, and bill recyclers. The Fluid Handling segment manufactures and sells various industrial and commercial valves and actuators; provides valve testing, parts, and services; manufactures and sells pumps and water purification solutions; distributes pipe, pipe fittings, couplings, and connectors; and designs, manufactures, and sells corrosion-resistant plastic-lined pipes and fittings. The Controls segment produces ride-leveling, air-suspension control valves for heavy trucks and trailers; pressure, temperature, and level sensors; ultra-rugged computers, measurement and control systems, and intelligent data acquisition products; and water treatment equipment. Crane Co. was founded in 1855 and is based in Stamford, Connecticut.

Advisors' Opinion:
  • [By Chuck Carnevale]

    Next, I run graphs on liquidity ratios and additional data on various valuation ratios to include price to book value (pb), price to cash flow (pcfl), price to free cash flow (pfcfl) and others that can be seen as options on the navigation bar to the left of the sample graph which only plots the current ratio (cr), a quick ratio (qr) and for those diehards concerned with volatility [size=11.0pt;line-height:115%; font-family:"Calibri","sans-serif";mso-ascii-theme-font:minor-latin;mso-fareast-font-family: Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA">��/p>

  • [By CRWE]

    Crane Co. (NYSE:CR) reported that Andrew L. Krawitt, Vice President, Treasurer and Principal Financial Officer, will be speaking at the 2012 Citi Global Industrials Conference in Boston on Wednesday, September 19, 2012 from 2:00 PM to 2:40 PM.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Crane (NYSE: CR  ) , whose recent revenue and earnings are plotted below.

  • [By Seth Jayson]

    Basic guidelines
    In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Crane (NYSE: CR  ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Crane doing by this quick checkup? At first glance, OK, it seems. Trailing-12-month revenue increased 0.6%, and inventory decreased 2.4%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue dropped 2.8%, and inventory contracted 2.4%. Over the sequential quarterly period, the trend looks OK but not great. Revenue dropped 0.4%, and inventory grew 2.0%.

Best Forestry Companies For 2014: Generac Holdlings Inc. (GNRC)

Generac Holdings Inc. designs, manufactures, and markets a range of generators and other engine powered products for the residential, light commercial, industrial, and construction markets in the United States and Canada. It offers generators and other products fueled by natural gas, liquid propane, gasoline, diesel, and Bi-Fuel under the Generac and Magnum brands. The company�s product line includes residential power products, commercial and industrial power products, and other products. Its residential power products comprise automatic residential standby generators that range in output from 6kW to 60kW; air-cooled residential standby generators, which range in outputs from 6kW to 20kW; and liquid-cooled generators that range in outputs from 20kW to 60kW. The residential power product line also includes portable generators consisting of GP series ranging from 1,850W to 17,500W for homeowners; the XG series ranging from 4,000W to 10,000W for the premium homeowner market; the XP series ranging from 4,000W to 8,000W for the professional contractor market; and the iX series ranging from 800W to 2,000W for the recreational market. The company�s industrial and commercial power products comprise light-commercial standby generators ranging from 22kW to 150kW for grocery stores, convenience stores, restaurants, gas stations, pharmacies, retail banks, and healthcare facilities; single-engine industrial generators, which range in output from 10kW to 600kW; and generator systems ranging from 20kW air-cooled generators to 3mW modular power system for the telecommunications market, as well as aftermarket service parts and RV generators. The company sells its generators through independent residential and industrial dealers, wholesalers, national accounts, private label arrangements, retailers, catalogs, e-commerce merchants, equipment rental companies and dealers, and construction companies. Generac Holdings Inc. was founded in 1959 and is headquartere d in Waukesha, Wisconsin.

Advisors' Opinion:
  • [By Rich Duprey]

    Generator maker Generac (NYSE: GNRC  ) announced this morning it had completed the refinancing of its senior secured�term loan credit facility and, as it previously promised, will use part of the proceeds to pay investors a special dividend of $5.00 per share,�payable on June 21�to stockholders of record on June 12.�

  • [By Eric Volkman]

    Generac (NYSE: GNRC  ) has reached abroad for its latest asset buy. The company announced Thursday that it inked an agreement to acquire Tower Light, an Italy-based company that develops and sells mobile light towers.

  • [By Roberto Pedone]

    One diversified machinery player that insiders are snapping up a decent amount of stock in here is Generac (GNRC), which designs, manufactures, and markets power generation equipment and other engine powered products for the residential, light commercial, industrial, and construction markets in the U.S., Canada, and internationally. Insiders are buying this stock into weakness, since shares have dropped notably by 22% so far in 2014.

    Generac has a market cap of $3 billion and an enterprise value of $3.8 billion. This stock trades at a fair valuation, with a trailing price-to-earnings of 17.6 and a forward price-to-earnings of 12.7. Its estimated growth rate for this year is -27%, and for next year it's pegged at 8.9%. This is not a cash-rich company, since the total cash position on its balance sheet is $173.16 million and its total debt is $1.11 billion.

    A director just bought 25,000 shares, or about $1.05 million worth of stock, at $42.17 per share.

    From a technical perspective, GNRC is currently trending above its 50-day moving average and below its 200-day moving average, which is neutral trendwise. This stock recently formed a triple bottom chart pattern at $39.08, $38.75 and $38.64 a share. Following that bottom, shares of GNRC have started to rebound sharply higher as the stock has pushed back above its 50-day moving average of $42.41 a share. That move has now pushed shares of GNRC within range of triggering a near-term breakout trade.

    If you're bullish on GNRC, then I would look for long-biased trades as long as this stock is trending above its 50-day at $42.41 a share or above more near-term support at $40 a share and then once it breaks out above some near-term overhead resistance levels at $45 to $45.72 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 1.17 million shares. If that breakout kicks off soon, then GNRC wi

Best Forestry Companies For 2014: Soul And Vibe Interactive Inc (SOUL)

Soul and Vibe Interactive, Inc., incorporated on 5, 2011, is a video and computer games company. The Company develops, publishes and digitally distributes interactive entertainment for video game consoles, mobile devices, and personal computers. It focuses on the development of its products for a variety of hardware platforms: video game consoles (for example: Xbox 360 and PlayStation 3), mobile (for example: Apple iOS and Android devices, and Windows Phones), and personal computers (for example: PC and Mac). The Company has five games, which consists of The Wheaties Challenge, Bugaboo, Grimwhiskers, a virtual-pet game that may bear a licensed-brand, and The Dragon Wars.

The Wheaties Challenge is an adrenaline-charged arcade sports compilation for console, mobile, and personal computer (PC)/Mac. The game promotes family health and wellness, is sponsored by General Mills, and features Wheaties as its signature brand. Bugaboo is an action-puzzle game for consoles, mobile devices and PCs. The core play mechanic is Shadow Weaving. Grimwhiskers is a side scrolling action game for consoles, mobile devices and PCs.

The Company competes with Zynga, Electronic Arts, Activision, Playdom, Ubisoft and Majesco.

Advisors' Opinion:
  • [By Peter Graham]

    Small cap stocks Soul and Vibe Interactive Inc (OTCBB: SOUL), Globalstar, Inc (OTCMKTS: GSAT) and Poly Shield Technologies Inc (OTCBB: SHPR) have been getting some attention lately in various investment newsletters or investor alerts with at least two of these stocks being the subject of some sort of paid stock promotional or investor relations type of activities. With that in mind, just how hot are these three small cap stocks for investors or traders? Here is a quick reality check:

  • [By Peter Graham]

    Small cap entertainment or gaming stocks Soul and Vibe Interactive Inc (OTCBB: SOUL), Elray Resources Inc (OTCMKTS: ELRA) and Players Network (OTCMKTS: PNTV) focus on entertaining consumers. However, its important to remember that consumers can be very fickle when it comes to entertainment or games. So should you be entertaining any of these small caps? Here is a closer look and a reality check:

Best Forestry Companies For 2014: Asante Gold Corp (ASE)

Asante Gold Corporation is a mineral exploration company involved in the acquisition and assessment of mineral properties in the Republic of Ghana. The Company is a gold royalty, exploration and development company. The Company is focused in Ghana, West Africa where it is exploring the Fahiakoba concession, a 22.07 square kilometers prospecting license located on strike with and between Perseus Mining's 4.32 million ounce Edikan Mine and AngloGold Ashanti's 60 million ounce Obuasi mine. It has a 100% interest in the Fahiakoba concession. ASG Mining Ltd. is the Company�� 100% owned Ghana subsidiary. Advisors' Opinion:
  • [By Namitha Jagadeesh]

    Greece�� ASE Index (ASE) retreated 4 percent today, pulled down by shares of lenders. National Bank of Greece SA tumbled 27 percent to 1.15 euros after announcing details of a share sale. Piraeus Bank SA slid 21 percent to 36 euro cents.

Best Forestry Companies For 2014: Stemline Therapeutics Inc (STML)

Stemline Therapeutics, Inc. (Stemline), incorporated on August 8, 2003, is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target both cancer stem cells (CSCs) and tumor bulk. The Company is developing two clinical-stage product candidates, SL-401 and SL-701, for which it holds global marketing rights. The indication for SL-401, a biologic-drug conjugate, is acute myeloid leukemia (AML). The indications for SL-701, a synthetic peptide vaccine, are pediatric and adult brain cancer. It has a platform, StemScreen, for the discovery of CSC-targeted compounds, from which it has discovered or validated several of its clinical and preclinical product candidates. Stemline�� StemScreen consists of StemScreen-1 and StemScreen-2 for the identification of CSC-directed compounds.

SL-301 is a small molecule gamma-secretase inhibitor that inhibits Notch, a pathway expressed by CSCs and tumor bulk of multiple cancer types. SL-101 is a monoclonal antibody-based (mAb -based) compound that targets CD123 and has shown in vitro activity against certain hematologic cancers. SL-201 is a small molecule active against certain hematologic and solid tumor types. SL-601 is a mAb-based compound that targets a cell surface marker on bladder CSCs, which is also expressed on a variety of other solid tumor types. It has also in-licensed certain intellectual property directed to mAb-based therapeutics to validated oncology targets, including Glypican-3, Tie-1, CD133, Frizzled, Smoothened and Patched.

SL-401 - An IL-3R-Directed Compound Targeting Cancer Stem Cells and Tumor Bulk

SL-401 is a clinically active biologic-drug conjugate consisting of human interleukin-3 (IL-3) genetically linked to a truncated version of diphtheria toxin. SL-401 targets the IL-3 receptor (IL-3R), which is overexpressed on both the CSCs and tumor bulk of multiple hematologic cancers, including AML. SL-401 has demonstrated preclinical in vit! ro and in vivo activity against both leukemia blasts (which includes tumor bulk) and CSCs of a range of human leukemia cell lines and primary leukemia cells from patients.

SL-701

SL-701 is a clinically active synthetic peptide vaccine that targets several epitopes on CSCs and tumor bulk of brain cancer. In two completed Phase 1/2 clinical trials, SL-701 demonstrated single agent anti-tumor activity in pediatric patients with newly diagnosed brainstem glioma (BSG) and other high-grade gliomas (HGGs) and in adult patients with refractory or recurrent GBM, and other HGGs.

StemScreen-1

StemScreen-1 is a drug discovery platform designed to identify CSC-targeted compounds based on the isolation of CSCs and evaluation of CSC gene expression profiles. CSCs are isolated from primary tumor tissue or cell lines, and then subjected to gene expression analysis using a variety of technologies, including microarray. A control tissue, such as normal bone marrow is analyzed as a comparator against the gene expression profile of the isolated CSCs. These data are then interfaced with an information base of compounds and their mechanisms of action (that is which gene products and pathways they impact). It has utilized StemScreen-1 to discover a number of its preclinical drug candidates. These include SL-201, SL-301, and SL-601. In addition, SL-401 demonstrated activity against CSCs as determined by both an in vitro colony formation and in vivo animal implantation assay, thereby validating certain StemScreen-1 anti-CSC assays.

StemScreen-2

StemScreen-2 is a high throughput drug discovery platform it is developing to discover anti-CSC compounds. StemScreen-2 utilizes a cell-based assay that can track and follow CSCs in their natural state during high throughput screening. In particular, StemScreen-2 utilizes a CSC-specific promoter linked to a reporter as a method for identifying and following CSCs in their native environment of surrounding tumor b! ulk. In t! his way, StemScreen-2 enables the identification of compound hits, in a high throughput manner, with anti-CSC activity.

The Company competes with Boston Biomedical, Inc., Eclipse Therapeutics, Inc., OncoMed Pharmaceuticals, Inc., Verastem, Inc., Astellas Pharma US, Inc., Boehringer Ingelheim GmbH, Dainippon Sumitomo Pharma Co. Ltd., Geron Corp., GlaxoSmithKline plc, ImmunoCellular Therapeutics, Ltd, Macrogenics Inc., Amgen, Inc., Pfizer Inc., Roche Holding AG, Sanofi U.S. LLC., Cyclacel Pharmaceuticals, Inc., Sunesis Pharmaceuticals Inc., Clavis Pharma ASA, Ambit Biosciences Corporation, Celgene Corporation, Eisai Co. Ltd., Celator Pharmaceuticals, Inc., Merck & Co., Inc., Eisai Co., Inc., Roche Holding AG, Novartis AG and Celldex Therapeutics, Inc.

Advisors' Opinion:
  • [By David Zeiler]

    3. Stemline Therapeutics Inc. (Nasdaq: STML): This biotech develops drugs that target cancer stem cells and tumors. Stemline went public January 29 at $10 a share and rose just 11.78% on its first day. But STML has climbed steadily since, and currently trades at $37.46, up 274.6% from its IPO price.

  • [By Jay Silverman]

    Some of the biggest leaders in that field, and there have been dozens in fields, if not more this year, such as Bluebird (BLUE) and Stemline Therapeutics (STML) and have all pulled back to significantly lower levels; even below, in Bluebird's case, the price that had actually opened up as an IPO, even though it's above its IPO price.

  • [By Keith Speights]

    Best-performing biotech IPO
    Stemline Therapeutics� (NASDAQ: STML  ) has only traded publicly this year, but what a year it's been. The stock's performance ranks Stemline as the best-performing biotech IPO so far in 2013. This week has been pretty good also, with shares moving up by 28%.

Thursday, March 26, 2015

Top 5 Mid Cap Companies To Invest In 2015

Top 5 Mid Cap Companies To Invest In 2015: Violin Memory In c (VMEM)

Violin Memory, Inc., incorporated on March 9, 2005, is pioneering a new class of flash-based storage systems that are designed to bring storage performance in-line with high-speed applications, servers and networks. The Companys Flash Memory Arrays are specifically designed at each level of the system architecture starting with memory and optimized through the array to leverage the inherent capabilities of flash memory and meet the sustained requirements of business-critical applications, virtualized environments and Big Data solutions in enterprise data centers. The Companys Velocity Peripheral Component Interconnect Express (PCIe), Flash Memory Cards leverage its persistent memory-based architecture in servers and are optimized for applications that require continuous access to quantities of low latency persistent memory located directly in servers.

The Companys storage systems are based on a four-layer hardware architecture, which is integrated wi th its Violin Memory Operating System (vMOS), software stack to optimize the management of flash memory at each level of its system architecture. The Companys Velocity PCIe Flash Memory Cards leverage its expertise in persistent memory-based storage and controller design, as well as its vMOS software stack, to offer a differentiated architecture in a deployable PCIe form factor.

Advisors' Opinion:
  • [By Steve Symington]

    What: Shares of Violin Memory, (NYSE: VMEM  ) plunged 48% Friday after the high-speed data storage specialist came up well short of analysts' estimates with its first quarterly report as a public company.

  • source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-5-mid-cap-companies-to-invest-in-2015.html

Wednesday, March 25, 2015

How to Lead by Example

We've heard it since kindergarten: the best way to lead is to lead by example. 

Whether it has to do with honesty, work ethic, or customer service, social norms are hugely influential in how we behave and treat others. And, of course, the best way to establish a social norm as a leader is to embody those traits that you want to see in others.

It sounds simple, but how do you actually implement it? 

Start with one thing at a time 
Building a culture of excellence, communication, and respect isn't going to happen overnight -- especially if you're just starting out on this whole leading by example thing. 

Instead of trying to fit in everything but the kitchen sink, sit down and think about the specific norms and traits you most want to see established. Better yet, make a list. It might have three items on it or fifteen, but writing it down will keep it fresh in your mind as you go through the process, and will help you stay focused on these big-ticket, big-picture goals. 

From there, choose one thing. Maybe your trait is "Listen to other people's opinions." Put it on Post-it notes, set a reminder on your phone -- whatever it takes, make it a priority to establish this habit over time. Every day, remind yourself to seek out and listen to the opinions of others.

10 Best Communications Equipment Stocks To Buy For 2015

Once it becomes second nature, say after two weeks, you can go to the next item on the list. It sounds slow perhaps, but do this every day over the course of a year and you've suddenly established 17 killer new habits that you can be proud of. 

Don't ask of others that which you won't do yourself 
If you want your team or your colleagues to deliver on time, be sure you deliver on time. If you want to see great customer service from others, be sure to give it yourself. 

When people see that you are willing and able to do what you say needs to be done, they'll be more likely to do it themselves. This is partially due to social norms (for better or for worse, we tend to mimic others' behaviors), but it's also partly because setting an example demonstrates that the behavior is possible. 

That is to say, sometimes it can be hard to believe that you can maintain patience and an upbeat attitude when a customer is being rude. But if you see someone else demonstrating how to do it, suddenly it's no longer an unattainable ideal. 

On that note, help others reach their potential 
Setting an example is a powerful way of teaching: you show how something gets done by doing it, and people learn by watching. 

And just like your kids, your colleagues see pretty much everything. What they might not see is all the intellectual work that goes into your new great habit; for example, maintaining your cool with that abusive customer. Everyone can see that you've done it, but maybe someone needs a bit more help in learning how to do it. 

If you suspect that might be the case (someone asking you, "Wow, how did you do that!?" is a great hint that it is), be very free with sharing your techniques. Maybe you counted to ten, or pretended the customer was in their underwear, or channeled the example of a really patient person you know.

Whatever it is, share your techniques with others so that they can also learn how to live up to your example. 

Take responsibility 
If you want other people to behave in a moral, professional, or innovative manner, they need to be empowered to take responsibility for their actions -- so of course it's imperative that you as well take responsibility for your actions.

That means that when you fail, own up to it. When you get it wrong, admit it. 

We all lose our cool at the wrong time or slip into a bad habit that we've been trying to break. These shortcomings don't make us losers, they make us human. 

But that doesn't mean they shouldn't be acknowledged and overcome. Taking responsibility for where you've gone wrong will not only humanize you with your colleagues, it will help give them the courage to try to follow your lead and learn from your mistakes. That's because you're showing that mistakes are OK and that they can be overcome. 

By showing up every day and taking responsibility for overcoming those mistakes, you're setting the most important example of all: that self-improvement and excellence are valid, important, and achievable goals. 

How one Seattle couple secured a $60K Social Security bonus -- and you can too
A Seattle couple recently discovered some little-known Social Security secrets that can boost many retirees' income by as much as $60,000. They were shocked by how easy it was to actually take advantage of these loopholes. And although it may seem too good to be true, it's 100% real. In fact, one MarketWatch reporter argues that if more Americans used them, the government would have to shell out an extra $10 billion… every year! So once you learn how to take advantage of these loopholes, you could retire confidently with the peace of mind we're all after, even if you're woefully unprepared. Simply click here to receive your free copy of our new report that details how you can take advantage of these strategies.

Monday, March 23, 2015

Top Beverage Stocks For 2014

Williams Capital Group’s Marc Riddick explains why he raised his price target on Keurig Green Mountain (GMCR) to $131 from $125:

Reuters

We are increasing our 12-month price target to $131.00, up from our prior price target of $125.00. Our price target represents a target multiple of 32x a blend of our F2014 and F2015 adjusted diluted earnings per share estimates. We believe that Keurig Green Mountain shares will be predominately driven by new products (Keurig 2.0 new hot beverage platform and Keurig Cold new at-home carbonated beverage platform) and other new relationships…

Our F2014 estimates assume a reduction in year-over-year revenue growth of 7.0% to $4.683 billion, (down from our prior estimate of 7.5%), a reduction in our operating margin estimate to expansion of approximately 216 basis points to 19.73% vs. 17.56% in F2013 (down from our prior expansion estimate of 257 basis points) and a reduction in EPS growth to 13.7% (down from our prior estimate of 13.8%). The adjustments to our full year estimates reflect F3Q 2014 results and a 280 basis point reduction of our operating margin estimate for F4Q due to increased expenses to support the new Keurig 2.0 rollout…

Top 10 Valued Stocks To Invest In 2015: Suntory Beverage & Food Ltd (STBFY)

Suntory Beverage & Food Limited is principally engaged in the manufacture and sale of beverages and food. The Company operates in two geographical segments. The Domestic segment is engaged in the manufacture and sale of various soft drinks within Japan, such as coffee drinks, mineral water, green tea drinks, tea drinks, carbonated drinks, fruit juice drinks, functional beverages, milk beverages, and food for specified health use, as well as syrup for general and business usage. The International segment is engaged in the manufacture and sale of carbonated drinks, fruit juice drinks, health food, seasoning, tea-based beverages and others, with operations in Europe, Oceania, Asia and the Americas. As of May 29, 2013, the Company had 80 subsidiaries and 10 associated companies. On October 15, 2013, the Company acquired Lucozade Ribena Suntory Limited. On December 12, 2013, the Company acquired Suntory Beverage & Food Europe Limited. Advisors' Opinion:
  • [By Charles Sizemore]

    Let�� start with Suntory Beverage & Food Limited (STBFY),which recently completed its acquisition of�Beam Inc., formerly the purest play on bourbon. Beam was the owner of the eponymous Jim Beam brand, as well as the higher-end Maker�� Mark and Knob Creek and the lower-end Old Crow.�Suntory is Japan�� leading spirits company, though most Americans will be unfamiliar with its Japanese whisky brands, such as Yamazaki and Hakushu. (Note for booze snobs: Japanese whisky��ike Scotch and Canadian whisky��s correctly spelled ��hisky.��American bourbon, Tennessee whiskey and Irish whiskey are correctly spelled ��hiskey.��

Top Beverage Stocks For 2014: Craft Brew Alliance Inc (BREW)

Craft Brew Alliance, Inc., incorporated on May 4, 1981, is an independent craft brewer. The Company is engaged in brewing, marketing and selling of craft beers in the United States. The Company operates two segments: Beer related operations and Pubs and Other. Beer related operations include the brewing and sale of craft beers from its five breweries. Pubs and Other operations primarily include its five pubs, four, of which are located adjacent to its breweries. The Company brews its Widmer Brothers, Redhook and Kona beers in each of its three mainland production breweries, including New Hampshire Brewery, Oregon Brewery and Washington Brewery. The Company also owns and operates a small manual style brewery, primarily used for small batch production at the Rose Quarter in Portland, Oregon. The Company�� beer portfolio is consisted of the Widmer Brothers, Redhook and Kona brand families. On May 2, 2011, the Company sold 42% interest in Fulton Street Brewery, LLC.

The Company�� Widmer Brothers Hefeweizen is a golden, cloudy wheat beer with a pronounced citrus aroma and flavor. This beer is usually served with a lemon slice. Its Drifter Pale Ale is brewed with generous amounts of summit hops. It also includes Drop Top Amber Ale and Rotator India Pale Ale. Initial beers in the series 924 series include the Nelson Imperial IPA and the Pitch Black IPA, which is a Pacific Northwest twist on a traditional IPA, brewed in the style of a Cascadian Dark. Beers in this brand are offered as a draft product and as a four pack for bottles. Widmer Brothers beers include Brothers��Reserve and Alchemy Project. Widmer Brothers seasonal beers are Citra Blonde, Okto, Brrr and W series.

The Redhook family of beers is consisted of sessionable (lower alcohol by volume) and approachable beers. Its Long Hammer IPA is the beer within the brand family and is English pub-style bitter ale with a bold hop aroma and profile that is not overpoweringly bitter. Its

Redhook Pilsner is a crisp, easy-! drinking, golden lager that is modeled after beers originally brewed in Plzen, Czechoslovakia. Redhook ESB is rich, full-bodied amber ale with a smooth flavor profile featuring toasted malts and a pleasant finishing sweetness. Its Copperhook Ale is copper-colored ale with caramel notes and a clean refreshing finish. The Company�� Blueline Series brand is offering from the Redhook brand family for the West Coast beer drinker. These beers are hand crafted by the brewers and are available at its Washington Brewery pub, as well as at select restaurants, bottle shops and public houses in the Seattle, Washington area. Its Brewery Backyard Series is produced at its New Hampshire brewery as a draft product available at the brewery�� pub and at select local establishments. Redhook seasonal beers include Nut Brown Ale, Winterhook Winter Ale and Wit.

The Company�� Kona Beers brand family is consisted of beers that deliver the essence of the Hawaiian Islands that is Always Aloha. The Company�� Longboard Island Lager is a traditionally brewed lager with a delicate, slightly spicy hop aroma that is complimented by a fresh, malt-forward flavor and a smooth, refreshing finish. Its Fire Rock Pale Ale is a crisp, Hawaiian Style pale ale with pronounced citrus and floral hop aromas and flavors that are backed up by a generous malt profile.

Kona seasonal beers include Koko Brown Ale, American brown ale with a deep amber color and rich mahogany hues. This ale has a smoky, roasted nut aroma and flavor, with a coconut twist. Koko Brown Ale is Kona�� spring seasonal. Its Pipeline Porter is smooth and dark, with a roasty aroma and earthy flavor. This ale is brewed with fresh 100% Kona coffee. Its Wailua Wheat is golden, sun-colored ale with a bright, citrusy flavor. This beer is brewed with a touch of tropical passion fruit to impart a slightly tart and crisp finish. Kona offers two variety packs: Island Hopper variety 12-packs and Big Kahuna variety 24-packs. Both packages include the brewe! ry�� Lo! ngboard Island Lager along with Fire Rock Pale Ale and then two of its Aloha series seasonal offerings: Koko Brown, Wailua Wheat and Pipeline Porter.

The Company competes with Heineken, Corona Extra and Guinness.

Advisors' Opinion:
  • [By Louis Navellier]

    The fantastic performance and growth of this company was noted by Portfolio Grader back in August and the stock was upgraded to an A. Shares of SAM stock remain a “strong buy” at the current price. When it comes to beer stocks to buy now, this is one of the most tempting.

    Best Booze Stocks to Buy Now -�Craft Brew Alliance (BREW)

    Craft Brew Alliance (BREW) makes craft beers under three very popular brands for beer aficionados. The Widmar Brothers, Redhook and Kona brands of beer have all received rave reviews … and that’s just one reason BREW is one of the best beer stocks to buy now.

Top Beverage Stocks For 2014: Coca-Cola Enterprises Inc. (CCE)

Coca-Cola Enterprises Inc. produces, distributes, and markets non-alcoholic beverages in Europe. It provides a range of beverage categories, including energy drinks, still and sparkling waters, juices, sports drinks, fruit drinks, coffee-based beverages, and teas. The company primarily offers its products under Coca-Cola, Diet Coke/Coke light, Fanta, Coca-Cola Zero, Capri Sun, Schweppes, Sprite, Chaudfontaine, MinuteMaid, and Dr. Pepper brands. It provides its products to customers and consumers through licensed territory agreements in Belgium, continental France, Great Britain, Luxembourg, Monaco, the Netherlands, Norway, and Sweden. Coca-Cola Enterprises Inc. was founded in 1986 and is based in Atlanta, Georgia.

Advisors' Opinion:
  • [By L.A. Little]

    Coca-Cola Enterprises Inc. (CCE) � is a consumer staple and has a lot less volatility than most stocks. As seen below, it has broken over multiple swing points on the short-term time frame.

  • [By Monica Gerson]

    Coca-Cola Enterprises (NYSE: CCE) is estimated to report its Q3 earnings at $0.80 per share on revenue of $2.16 billion.

    Autoliv (NYSE: ALV) is projected to report its Q3 earnings at $1.34 per share on revenue of $2.06 billion.

  • [By Jon C. Ogg]

    Coca-Cola Enterprises Inc. (NYSE: CCE) was raised to the prized Conviction Buy List from Neutral with a $47 price target at Goldman Sachs, sending shares up almost 3% to $38.50 on the upgrade.

  • [By Marc Bastow]

    Non-alcoholic beverage distributor Coca-Cola Enerprises (CCE) raised its quarterly dividend 25% to 25 cents per share, payable on Mar. 20 to shareholders of record as of Mar. 7.
    CCE Dividend Yield: 2.25%

Top Beverage Stocks For 2014: Dr Pepper Snapple Group Inc (DPS)

Dr Pepper Snapple Group, Inc. (DPS), incorporated on October 24, 2007, is an integrated brand owner, manufacturer and distributor of non-alcoholic beverages in the United States, Canada and Mexico with a diverse portfolio of flavored (non-cola) carbonated soft drinks (CSDs) and non-carbonated beverages (NCBs), including ready-to-drink teas, juices, juice drinks and mixers. The Company operates in three segments: Beverage Concentrates, Packaged Beverages and Latin America Beverages. The Company primarily serves two groups of customers: bottlers and distributors and retailers. As of December 31, 2011, it operated 20 manufacturing facilities across the United States and Mexico, excluding its manufacturing facility for its joint venture with Acqua Minerale San Benedetto. Effective March 1, 2013, it acquired Dr. Pepper/7-UP Bottling Co of the West, a producer and wholesaler of bottled soft drinks.

Beverage Concentrates

The Company�� Beverage Concentrates segment is principally a brand ownership business. In this segment the Company manufactures and sells beverage concentrates in the United States and Canada. Most of the brands in this segment are CSD brands. Its brand portfolio includes CSD brands, such as Dr Pepper, Sunkist soda, 7UP, A&W, Canada Dry, Crush, Squirt, Penafiel and Schweppes. Beverage concentrates are shipped to third party bottlers, as well as to its own manufacturing systems, who combine them with carbonation, water, sweeteners and other ingredients, package it in PET containers, glass bottles and aluminum cans, and sell it as a finished beverage to retailers. Beverage concentrates are also manufactured into syrup, which is shipped to fountain customers, such as fast food restaurants, who mix the syrup with water and carbonation to create a finished beverage at the point of sale to consumers. Its Beverage Concentrates brands are sold by its bottlers, including its own Packaged Beverages segment, through all retail channels, including supermarkets, fountains, mas! s merchandisers, club stores, vending machines, convenience stores, gas stations, small groceries, drug chains and dollar stores.

Packaged Beverages

The Company�� Packaged Beverages segment is principally a brand ownership, manufacturing and distribution business. In this segment, it primarily manufacture and distribute packaged beverages and other products, including its brands, third party owned brands and certain private label beverages, in the United States and Canada. Key NCB brands in this segment include Hawaiian Punch, Snapple, Mott's, Yoo-Hoo, Clamato, Deja Blue, AriZona, FIJI, Mistic, Nantucket Nectars, ReaLemon, Mr and Mrs T, Rose's and Country Time. Key CSD brands in this segment include 7UP, Dr Pepper, A&W, Sunkist soda, Canada Dry, Squirt, RC Cola, Big Red, Sun Drop, Diet Rite, IBC and Vernors. Approximately 87% of its 2011 Packaged Beverages net sales of branded products come from its own brands, with the remaining from the distribution of third party brands, such as Big Red, AriZona tea, FIJI mineral water, Neuro beverages, Vita Coco coconut water and Hydrive energy drinks. A portion of its sales also comes from bottling beverages and other products for private label owners or others, which is also referred to as contract manufacturing. Its Packaged Beverages��products are manufactured in multiple facilities across the United States and are sold or distributed to retailers and their warehouses by itsown distribution network or by third party distributors. The Company sells its Packaged Beverages��products both through its Direct Store Delivery system (DSD), supported by a fleet of approximately 6,000 vehicles and 12,000 employees, including sales representatives, merchandisers, drivers and warehouse workers, as well as through its Warehouse Direct delivery system (WD), both of which include the sales to retail channels, including supermarkets, fountain channel, mass merchandisers, club stores, vending machines, convenience stores, gas stations, small groce! ries, dru! g chains and dollar stores.

Latin America Beverages

The Company�� Latin America Beverages segment is a brand ownership, manufacturing and distribution business. This segment participates mainly in the carbonated mineral water, flavored CSD, bottled water and vegetable juice categories, with particular strength in carbonated mineral water, vegetable juice categories and grapefruit flavored CSDs. Its brands include Squirt, Penafiel, Aguafiel, Crush and Clamato.

In Mexico, it manufactures and distributes its products through its bottling operations and third party bottlers and distributors. In the Caribbean, it distributes its products through third party bottlers and distributors. In Mexico, it also participate in a joint venture to manufacture Aguafiel brand water with Acqua Minerale San Benedetto. The Company sells its finished beverages through Mexican retail channels, including mom and pop stores, supermarkets, hypermarkets, and on premise channels.

The Company competes with The Coca-Cola Company (Coca-Cola), PepsiCo, Inc. (PepsiCo), Nestle, S.A. (Nestle), Kraft Foods Inc. (Kraft) and The Cott Corporation (Cott).

Advisors' Opinion:
  • [By Tom Rojas var popups = dojo.query(".socialByline .popC"); popups.forEach(func]

    Keurig Green Mountain Inc.(GMCR) signed a deal with Dr Pepper Snapple Group Inc.(DPS) to sell capsules that make its sodas in Keurig’s planned cold-drink machine, giving the maker of coffee and brewing machines two of the top three soda companies on a platform central to its long-term expansion plans.

  • [By Ben Levisohn]

    Shares of Dr. Pepper (DPS) have been trouncing those of Coca-Cola (KO), PepsiCo (PEP) and even Monster Beverage (MNST) this year–but today it’s getting pounded thanks to a Citigroup downgrade.

    Sure, it’s been a great year for Dr. Pepper Snapple. It’s gained 21% so far this year, easily besting PepsiCo’s 6.5% rise, Monster Beverages 6.9% advance and Coca-Cola’s 1.4 % increase. Now, however, it’s time for Dr. Pepper’s shares to “take a breather,” explain Citigroup’s Wendy Nicholson and Peter Chun:

    Dr. Pepper Snapple has appreciated 22% year-to-date, far outpacing Coca-Cola, PepsiCo, Monster Beverage and the S&P500. This relative outperformance comes despite Dr. Pepper Snapple’s outlook for only 0%-1% top line growth (with volumes expected to be down more than 1%) and 6%-8% EPS growth in 2014. With this big move in the stock now behind us, we downgrade�Dr. Pepper Snapple to a Neutral rating. Our reasons for the downgrade are as follows:

    ��U.S. CSD category growth has improved, but not by much;
    ���r. Pepper Snapple intends to reduce ad spending while its big competitors intend to increase it, and we fear that this could pressure�Dr. Pepper Snapple’s market shares;
    ��Snapple has historically been an iconic brand, but it is too small to really move the needle for Dr. Pepper Snapple , and overall,�Dr. Pepper Snapple’s stills portfolio is struggling;
    ���r. Pepper Snapple’s RCI initiatives are impressive and ongoing, but despite lower advertising spending this year, we don�� expect much margin expansion, and we wonder if the balance sheet improvements are largely behind us;
    ��From a stock market perspective, investor rotation away from EM�� (which has benefitted Dr. Pepper Snapple) has probably largely played out;
    ��DPS�� cash flow has been terrific for a while ��but an extra ��iss��from either Coca-Cola or Pep

  • [By Ben Levisohn]

    The news that someone somewhere was in talks with SodaStream actually broke April 16, when Israeli website, Calcalist noted that SodaStream was talking with either PepsiCo (PEP), Dr. Pepper Snapple (DPS) or Starbucks. As a result, “the cost of higher-strike options increased at a faster pace than the decline in lower-strike options,” noted Interactive Broker’s Andrew Wilkinson at the time.

Best Restaurant Companies To Watch In Right Now

Best Restaurant Companies To Watch In Right Now: Noodles & Co (NDLS)

Noodles & Company, incorporated on December 19, 2002, is a casual restaurant concept offering lunch and dinner. The Company offers noodle and pasta dishes, staples of many cuisines, with the goal of delivering fresh ingredients and flavors globally under one roof from Pad Thai to Mac & Cheese. The Companys globally inspired menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and sandwiches, which are served on china by its friendly team members.

As of May 28, 2013, including the 16 Company owned restaurants and one franchise restaurant opened in 2013. The Company opened 39 new company owned restaurants and six franchise restaurants. In 2012, the Company began using Your World Kitchen to describe the breadth of its offering and its customers' dining experience.

Advisors' Opinion:
  • [By Jon C. Ogg]

    Before you consider this just to be a bit of IPO pondering, take a step back and understand that some of this list membership already hasfiled to come public or actually hasmade it public recently. Boise Cascade Co. (NYSE: BCC), CDW Corp. (NASDAQ: CDW), Coty Inc. (NYSE: COTY), Global Brass and Copper Holdings Inc. (NYSE: BRSS), Noodles & Company (NASDAQ: NDLS), Restoration Hardware Holdings Inc. (NYSE: RH), Sprouts Farmers Market Inc. (NASDAQ: SFM) and many others are on the list and have made it to the post-IPO stage in the stock market.

  • [By Valuentum]

    After the extremely positive post-IPO fortune of fast food concept Noodles & Co (NDLS), the surging IPO of Potbelly (PBPB) caught our attention. Let's take a look at the prospects of this Chicago-based sandwich chain.

  • [By John Udovich]

    At the end of last week, small cap restaurant stockZoe's Kitchen Inc (NYSE: ZOES) had its IPO with some pundits saying its potentially the next Chipotle Mexican Grill, Inc (NYSE: CMG), meaning its worth taking a! closer look at the stock along with Noodles & Co (NASDAQ: NDLS), Potbelly Corp (NASDAQ: PBPB) and Bloomin' Brands Inc (NASDAQ: BLMN) which are all restaurant stocks that also had relatively recent IPOs.

  • [By Daniel Sparks]

    Fool contributor Daniel Sparks doesn't think highly of Noodles & Company's (NASDAQ: NDLS  ) stock after its hyped IPO. In the video below he explains why Noodles is probably not the next Chipotle Mexican Grill (NYSE: CMG  ) , a fast-casual concept that has seenmind-bogglingsuccess since the company went public.

  • source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/best-restaurant-companies-to-watch-in-right-now-3.html

Saturday, March 21, 2015

Top Biotech Stocks For 2014

Popular Posts: Hottest Healthcare Stocks Now – INO CNC WCG MNKD7 Biotechnology Stocks to Buy NowHottest Healthcare Stocks Now – INO VRX EXAS AGN Recent Posts: Biggest Movers in Healthcare Stocks Now – ARIA KERX INCY HAE Biggest Movers in Technology Stocks Now – DWRE YHOO CERN BRKR Hottest Financial Stocks Now – TPL CG AGII CIB View All Posts 10 Insurance Stocks to Sell Now

The overall ratings of 10 insurance stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

Top 10 Gas Utility Companies For 2015: Amgen Inc.(AMGN)

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body?s response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Advisors' Opinion:
  • [By Sean Williams]

    Amgen (NASDAQ: AMGN  )
    Google may be the kingpin of all perk-oriented companies, but there are few companies out there that gear�perks more toward family life than biotechnology giant Amgen. All employees enjoy 17 paid holidays during the year, which includes two paid week-long shutdowns each year�on top of three weeks of personal vacation. Other perks include one-on-one nutritional counseling, on-site child rearing classes, adoption assistance, and a variety of work options like telecommuting and flex schedules. These perks are available to all employees regardless of gender, but in households where childrearing falls to the female, these amenities show that Amgen is doing what it can to support its employees in both their work and family lives.

Top Biotech Stocks For 2014: Genomic Health Inc (GHDX)

Genomic Health, Inc. (Genomic Health), incorporated in August 2000, is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Its Oncotype DX platform utilizes quantitative genomic analysis known as reverse transcription polymerase chain reaction (RT-PCR), in standard tumor pathology specimens to provide tumor-specific information, or the oncotype of a tumor. As of February 2012, Oncotype DX was evaluated in invasive breast cancer in 13 clinical studies involving more than 4,000 breast cancer patients worldwide. Genomic Health offers its Oncotype DX tests as a clinical service, where it analyzes the expression levels of genes in tumor tissue samples and provide physicians with a quantitative gene expression profile expressed as a single quantitative score, which it calls a Recurrence Score, for invasive breast cancer and colon cancer and a DCIS Score for DCIS. Its Oncotype DX breast cancer test analyzes the expression levels of 21 genes and Oncotype DX colon cancer test analyzes the expression levels of 12 genes. In March 2012, the Company established a wholly owned subsidiary, InVitae Corporation.

Oncotype DX Platform

The Company�� Oncotype DX platform uses its RT-PCR approach to improve cancer treatment decisions. Its diagnostic approach correlates gene expression to clinical outcomes and provides an individualized analysis of each patient's tumor. The Company has built a diagnostic infrastructure that allows it to move from research into development through to processing actual patient samples in its clinical reference laboratory. The Company offers Oncotype DX tests as clinical laboratory services. Its technology allows the Company to analyze tumor tissue samples in its clinical reference laboratory and provide physicians with genomic information specific to the patient'! s tumor. It analyzes tissues that are handled, processed and stored under routine clinical pathology laboratory practices.

Oncotype DX Breast Cancer Test

To develop its Oncotype DX breast cancer test, the Company evaluated 250 genes in three independent clinical studies, which identified a 21-gene panel whose composite gene expression profile can be represented by a breast cancer Recurrence Score. The Company conducted studies of its Oncotype DX breast cancer test with clinical samples from postmenopausal women with invasive breast cancer who were treated with aromatase inhibitors. In March 2010, the Journal of Clinical Oncology published results from a European study using its test to analyze tumor samples from over 1,200 patients in the ATAC (Arimedix, Tamoxifen, Alone or in Combination) trial, which established the use of aromatase inhibitors for adjuvant treatment of postmenopausal women with hormone receptor-positive breast cancer. The study demonstrated that, along with other standard measures, such as tumor size, its Oncotype DX breast cancer test contributes independently to provide a more complete picture of prognosis for N- and N+ patients treated with aromatase inhibitors.

In December 2011, the Company presented positive results from the ECOG E5194 DCIS clinical validation study at SABCS. The study met its primary endpoint by demonstrating that a pre-specified Oncotype DX DCIS Score can predict the risk of local recurrence, defined as either the development of a new invasive breast cancer or the recurrence of DCIS in the same breast. In December 2011, the Company made Oncotype DX available for patients with ductal carcinoma in situ (DCIS), of the breast, a pre-invasive form of breast cancer. The launch of Oncotype DX for DCIS patients was based on positive results presented from a clinical validation study of Oncotype DX breast cancer test in patients with DCIS, conducted by the Eastern Cooperative Oncology Group (ECOG), a clinical trials cooperative! group su! pported by the National Cancer Institute.

Oncotype DX Colon Cancer Test

The Company developed its gene panel by identifying 761 cancer-related genes through review of existing research literature and computer analysis of genomic databases. The 761 candidate genes were also examined to determine whether they would be useful beyond other key variables including tumor stage, tumor grade, lymph nodes examined and MMR/MSI. It selected a final set of 12 genes, which were then independently evaluated in a validation study of over 1,400 stage II colon cancer patients from the Quick and Simple and Reliable (QUASAR), randomized study of adjuvant chemotherapy in the United Kingdom. This international, multi-center randomized trial examined the recurrence risk and the benefit associated with 5-fluorouracil/leucovorin, or 5FU/LV, adjuvant chemotherapy. Gene expression was quantified by RT-PCR from manually microdissected FPE primary colon cancer tissue, and recurrence-free interval, disease-free survival and overall survival were analyzed. In January 2012, the Company presented positive results of the first clinical decision making study of the Oncotype DX colon cancer test that shows that Recurrence Score result has a significant impact on treatment recommendations for stage II colon cancer patients.

The Company competes with General Electric Company, Hologic, Inc., Novartis AG, Myriad Genetics, Inc., Qiagen N.V., Response Genetics, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Roche Holding, Ltd, Siemens AG and Johnson & Johnson.

Advisors' Opinion:
  • [By John Udovich]

    Small cap genomics stocks Rosetta Genomics Ltd (NASDAQ: ROSG), Genomic Health, Inc (NASDAQ: GHDX) and CollabRx Inc (NASDAQ: CLRX) are at the forefront of genomics testing�or research. I should mention that Wikipedia defines genomics�as a�discipline in genetics that applies recombinant DNA, DNA sequencing methods and bioinformatics to sequence, assemble and analyze the function and structure of genomes (the complete set of DNA within a single cell of an organism). A 2013 Booz Allen Hamilton report on the sector noted that in�2011, the US genetic and genomic clinical testing market size was estimated to be $5.9 billion while the�number of available tests has grown substantially from 1,680 just 4 years ago to 2,886 in 2012.

  • [By Sean Williams]

    What: Shares of Genomic Health (NASDAQ: GHDX  ) , a provider of genome-based clinical diagnostic tests, popped as much as 10% following the release of its first-quarter results.

Top Biotech Stocks For 2014: PTC Therapeutics Inc (PTCT)

PTC Therapeutics, Inc., incorporated on March 31, 1998 , is a biopharmaceutical company focused on the discovery and development of orally administered, small-molecule drugs that target post-transcriptional control processes. The Company�� lead product candidate includes ataluren, which is used for the treatment of patients with genetic disorders that arise from a type of genetic mutation known as a nonsense mutation. Ataluren is in late stage clinical development for the treatment of Duchenne muscular dystrophy caused by nonsense mutations (nmDMD) and cystic fibrosis caused by nonsense mutations (nmCF).

Ataluren is orally administered small-molecule compound that targets nonsense mutations. The Company is engaged in the development of ataluren for the treatment of genetic disorders in, which a nonsense mutation is the cause of the disease. Genetic tests are available for many genetic disorders, including Duchenne muscular dystrophy and cystic fibrosis, to determine if the underlying cause is a nonsense mutation. The EMA has designated ataluren as an orphan medicinal product for the treatment of nmDMD and nmCF. During the year ended December 31, 2012, the Phase III clinical trial completed. The Company�� Ataluren clinical trials in patients with nonsense mutation genetic disorders include Ataluren for nmDMD: Phase 2b clinical trial complete; Confirmatory Phase III clinical trial initiated, and Ataluren for nmCF: Phase III trial completed.

Advisors' Opinion:
  • [By WWW.DAILYFINANCE.COM]

    Records fell on Wall Street Friday as another solid report on housing lifted the market for the second day in a row. There's a three-day weekend coming up -- something that often prompts investor caution -- but the gains were broad-based even though volume was fairly light. The VIX, which measures volatility, fell to its lowest level this year. The Dow Jones industrial average (^DJI) gained 63 points, the Nasdaq composite (^IXIC) rose 31, and the Standard & Poor's 500 index (^GPSC) added 8, topping the record high set last week. The Dow Transportation average also raced to an all-time high, lifted by airline stocks. United (UAL) soared more than 4 percent; Delta (DAL) gained more than 1 percent and Southwest (LUV) gained 2 percent. Southwest is at an all-time high, up 79 percent from a year ago. New home sales bounced back with a better than expected 6.4 percent increase last month. Lennar (LEN) and D.R. Horton (DHI) both rose 4 percent. Pulte (PHM), Beazer (BZH) and Hovnanian (HOV) also solid posted gains. Earnings continue to drive retail stocks. Gap (GPS) edged higher even though net fell. Foot Locker (FL) gained 1½ percent after topping expectations. GameStop (GME) rose 4 percent. Its net rose, helped by the rollout last year of new Xbox and PlayStation consoles. Zumiez (ZUMZ) rose 5½ percent on an earnings beat. But Aeropostale (ARO) tumbled 24 percent. Its loss widened and sales declined. The retailer continues to struggle with teen fashion trends. Also on the earnings front, TiVo (TIVO) rose 2 percent as it swung to a profit from a year ago loss. It also reported an increase in the number of subscribers. Hewlett-Packard (HPQ) rose 6 percent on news the company plans to eliminate up to 16,000 additional workers in an effort to cut costs. And several stocks extended big moves from yesterday. Best Buy (BBY) rose more than 3 percent for the second straight day after earnings beat expectations. Isis Pharmaceuticals (ISIS) jumped
  • [By John Kell]

    PTC Therapeutics Inc.(PTCT) said the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative opinion on the biopharmaceutical company’s marketing authorization application for its muscular dystrophy treatment. Shares slumped 21% to $20.60 in premarket trading.

Top Biotech Stocks For 2014: OvaScience Inc (OVAS)

OvaScience, Inc., incorporated on April 5, 2011, is a life science company developing products to improve the treatment of female infertility based on recent scientific discoveries about the existence of egg precursor cells. The Company holds license from Massachusetts General Hospital (MGH) to an issued patent and various patent applications directed to methods of identifying and purifying egg precursor cells, compositions comprising egg precursor cells and methods of using egg precursor cells to treat infertility and related disorders. The Company�� product candidates are AUGMENT and OvaTure. The Company�� designs AUGMENT to treat infertility due to poor egg quality.

The Company�� first product candidate is AUGMENT, stands for autologous germline mitochondria energy transfer. It designs AUGMENT to increase the success of in vitro fertilization (IVF) by isolating fresh mitochondria from a woman's own egg precursor cells and then adding the mitochondria into the woman's egg during IVF. Its second product candidate is OvaTure. OvaTure involves the creation of mature fertilizable eggs from a woman's own egg precursor cells. If successful, this would allow women with compromised eggs due to age or other factors to undergo IVF using their own higher quality eggs.

The Company competes with Novocellus Ltd., Auxogyn, Inc, and Ovacyte LLC.

Advisors' Opinion:
  • [By John Udovich]

    On Thursday, small cap infertility stock OvaScience Inc (NASDAQ: OVAS) surged 23.63% plus shares are up 372.9% since the start of the year���meaning its worth taking a closer look at the stock along with the performance of female or reproductive health stocks the Female Health Co (NASDAQ: FHCO) and�Utah Medical Products, Inc (NASDAQ: UTMD)�along with the Vanguard Health Care ETF (NYSEARCA: VHT).

Top Biotech Stocks For 2014: Acceleron Pharma Inc (XLRN)

Acceleron Pharma Inc., incorporated on June 13, 2003, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. The Company�� research focuses on the biology of the Transforming Growth Factor-Beta (TGF-b) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body. By coupling its discovery and development expertise, including its knowledge of the TGF-b superfamily, with its internal protein engineering and manufacturing capabilities, it has built a productive research and development platform that has generated clinical and preclinical protein therapeutic candidates with mechanisms of action.

The Company focuses on discovering and developing protein therapeutics that target a group of approximately 30 secreted proteins, or ligands, that are collectively referred to as the TGF-b superfamily. These ligands bind to subsets of 12 different receptors on the surface of cells, triggering intra-cellular changes in gene expression that guide cell growth and differentiation. The TGF-b superfamily ligands and their receptors represent an under-explored and diverse set of drug targets with the potential to yield therapeutics that modulate the growth and repair of diseased cells and tissues.

The Company has three internally discovered protein therapeutic candidates that are being studied in 12 ongoing Phase 2 clinical trials, focused on cancer and rare diseases. The Company�� two advanced protein therapeutic candidates, sotatercept and ACE-536, promote red blood cell production through a novel mechanism. Together with its collaboration partner, Celgene Corporation, the Company is developing sotatercept and ACE-536 to treat anemia and associated complications in patients with b-thalassemia and myelodysplastic syndromes (MDS). These red blood cell disorders are generally unresponsive to approved dru! gs. The Company�� third clinical stage protein therapeutic candidate, dalantercept, is designed to inhibit blood vessel formation through a mechanism that is distinct from, and potentially synergistic with, the dominant class of cancer drugs that inhibit blood vessel formation, the vascular endothelial growth factor (VEGF) pathway inhibitors. The Company is developing dalantercept primarily for use in combination with these products to produce better outcomes for cancer patients.

The Company and Celgene have conducted six human clinical trials with sotatercept in over 160 healthy volunteers and cancer patients. The Company has conducted one clinical trial with ACE-536 in healthy volunteers. In these studies, both sotatercept and ACE-536 caused a dose-dependent increase in the number of red blood cells. Based on these results, the Company and Celgene have initiated Phase II clinical trials with each of these protein therapeutic candidates in b-thalassemia and MDS. In the ongoing trial of sotatercept in patients with b-thalassemia, the Company has observed encouraging, dose-dependent increases in hemoglobin in a subset of patients at the two lowest dose levels.

Sotatercept is a soluble receptor fusion protein consisting of the extracellular domain of the activin receptor type IIA (ActRIIA) linked to the Fc domain of human IgG1. Sotatercept acts as a protein trap for TGF-b superfamily ligands that signal through the ActRIIA receptor. Sotatercept has increased red blood cells in multiple clinical trials. ACE-536 is a soluble receptor fusion protein consisting of a modified extracellular domain of the activin receptor type IIB (ActRIIB) linked to the Fc domain of human IgG1.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Shares of Acceleron Pharma (NASDAQ: XLRN) got a boost, shooting up 16.39 percent to $39.42 after Form 8-K for Acceleron Pharma showed that Celgene (NASDAQ: CELG) will buy 1.1 million shares for $47.15 million.

  • [By Monica Gerson]

    Breaking news

    Acceleron Pharma (NASDAQ: XLRN) today announced that it has commenced an underwritten public offering of $100 million of its common stock. To read the full news, click here. XenoPort (NASDAQ: XNPT) announced today that it intends to offer and sell 10,000,000 shares of its common stock, subject to market and other conditions, in an underwritten public offering. To read the full news, click here. Affymetrix (NASDAQ: AFFX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its CytoScan庐 Dx Assay. To read the full news, click here. Verizon Communications (NYSE: VZ) and Intel (NASDAQ: INTC) today announced an agreement for Verizon to purchase from Intel the assets of Intel Media, a business division dedicated to the development of Cloud TV products and services. To read the full news, click here.

    Posted-In: Evercore Partners US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

Top Biotech Stocks For 2014: Exelixis Inc.(EXEL)

Exelixis, Inc., a biotechnology company, develops small molecule therapies for the treatment of cancer. It focuses on developing Cabozantinib, an inhibitor of tumor growth, metastasis, and angiogenesis that target MET, VEGFR2, and RET, which are key kinases involved in the development and progression of various cancers. The cabozantinib is in Phase III clinical trial for the treatment for medullary thyroid cancer. The company also engages in various clinical programs for cabozantinib focused on the treatment of metastatic castration-resistant prostate cancer, ovarian cancer, breast cancer, renal cell carcinoma, non-small cell lung cancer, hepatocellular cancer, and melanoma. In addition, Exelixis, Inc. involves in developing a portfolio of other novel compounds to address serious unmet medical needs through collaborations with various pharmaceutical and biotechnology companies, including Bristol-Myers Squibb Company, sanofi-aventis, Genentech, Inc., Boehringer Ingelheim Gm bH, and GlaxoSmithKline and Daiichi Sankyo Company Limited. Its products under development through collaborations include XL475, XL281, XL139, and XL413 inhibitors; ROR antagonists; therapies targeted against LXR, a nuclear hormone receptor implicated in various cardiovascular and metabolic disorders; XL147, XL765, and isoform-selective PI3K inhibitors; XL518, a small-molecule inhibitor of MEK; sphingosine-1-phosphate type 1 receptor; XL880 inhibitor; and therapies targeted against the mineralocorticoid receptor, a nuclear hormone receptor implicated in various cardiovascular and metabolic diseases. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California.

Advisors' Opinion:
  • [By Eddie Staley]

    Exelixis (NASDAQ: EXEL) shares shot up 21.18 percent to $4.03 after the company announced positive phase 3 data for coBRIM.

    Shares of Kandi Technolgies Group (NASDAQ: KNDI) got a boost, shooting up 20.24 percent to $17.70 on report of a 238% rise in EV sales.

  • [By John Kell var popups = dojo.query(".socialByline .popC"); popups.forEach(func]

    Among the companies with shares expected to actively trade in Wednesday’s session are American Apparel Inc.(APP), Exelixis Inc.(EXEL) and Francesca's Holdings Corp.(FRAN)

  • [By Roberto Pedone]

    Another under-$10 biotechnology player that's starting to trend within range of triggering a near-term breakout trade is Exelixis (EXEL), which develops small molecule therapies for the treatment of cancer in the U.S. This stock has been crushed by the bears so far in 2014, with shares down sharply by 41%.

    If you look at the chart for Exelixis, you'll notice that EXEL has been trending sideways and consolidating for the last two months and change, with shares moving between $3.02 on the downside and $3.84 on the upside. Shares of EXEL are starting to spike higher today right off its 50-day moving average of $3.42 a share. That spike is quickly pushing shares of EXEL within range of triggering a near-term breakout trade above some key overhead resistance levels.

    Market players should now look for long-biased trades in EXEL if it manages to break out above some near-term overhead resistance levels at $3.55 to $3.63 a share and then once it clears more resistance at $3.84 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 4.85 million shares. If that breakout kicks off soon, then EXEL will set up to re-test or possibly take out its next major overhead resistance level at its March gap-down-day high of $4.50 a share. Any high-volume move above $4.50 will then give EXEL a chance to re-fill some of its previous gap-down-day zone that started at $6.66 a share.

    Traders can look to buy EXEL off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.18 to $3.02 a share. One can also buy EXEL off strength once it starts to move above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By Selena Maranjian]

    D. E. Shaw reduced its stake in lots of companies, including Acadia Pharmaceuticals (NASDAQ: ACAD  ) and Exelixis (NASDAQ: EXEL  ) . Acadia has skyrocketed over the past year, rising more than 10-fold, on high hopes for its pimavanserin drug, which treats psychosis in patients with Parkinson's disease. If the drug gains FDA approval, it will enjoy little competition and could be a big winner for Acadia. The company thinks the drug might be effective against psychosis related to Alzheimer's disease as well and is conducting trials for that, too. Acadia is also raising about $100 million via a secondary stock offering to fund ongoing and future trials.